| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.046 | 0.4 |